Stryker Stock EBITDA

SYK Stock  USD 327.45  8.58  2.55%   
Stryker fundamentals help investors to digest information that contributes to Stryker's financial success or failures. It also enables traders to predict the movement of Stryker Stock. The fundamental analysis module provides a way to measure Stryker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stryker stock.
Last ReportedProjected for Next Year
EBITDAB5.2 B
EBITDA is expected to rise to about 5.2 B this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Stryker Company EBITDA Analysis

Stryker's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Stryker EBITDA

    
  4.95 B  
Most of Stryker's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Stryker EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Stryker is extremely important. It helps to project a fair market value of Stryker Stock properly, considering its historical fundamentals such as EBITDA. Since Stryker's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Stryker's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Stryker's interrelated accounts and indicators.
0.970.940.980.990.990.870.740.950.94-0.50.350.980.620.940.98-0.910.88-0.970.88-0.690.6-0.520.410.110.66
0.970.881.00.990.930.920.750.870.95-0.370.290.930.70.850.95-0.810.84-0.910.78-0.590.65-0.560.380.030.71
0.940.880.890.910.960.670.630.920.92-0.60.50.980.380.960.95-0.940.87-0.970.91-0.770.53-0.60.340.050.63
0.981.00.890.990.950.910.750.90.95-0.410.290.950.690.870.96-0.840.85-0.930.81-0.610.65-0.550.40.050.7
0.990.990.910.990.960.890.750.910.95-0.470.30.960.640.890.97-0.860.87-0.940.83-0.650.64-0.550.370.090.68
0.990.930.960.950.960.820.710.970.9-0.580.390.980.540.980.98-0.960.89-0.970.92-0.740.55-0.470.420.160.6
0.870.920.670.910.890.820.680.770.76-0.110.210.760.860.690.8-0.660.69-0.750.63-0.460.56-0.310.410.170.55
0.740.750.630.750.750.710.680.590.76-0.430.210.730.360.580.76-0.60.63-0.660.52-0.390.95-0.510.61-0.130.77
0.950.870.920.90.910.970.770.590.81-0.60.30.930.560.980.94-0.970.86-0.930.93-0.780.43-0.40.370.190.47
0.940.950.920.950.950.90.760.760.81-0.50.380.960.470.840.94-0.80.85-0.930.77-0.590.7-0.690.33-0.080.79
-0.5-0.37-0.6-0.41-0.47-0.58-0.11-0.43-0.6-0.5-0.03-0.610.17-0.68-0.610.68-0.570.6-0.650.53-0.330.26-0.26-0.19-0.32
0.350.290.50.290.30.390.210.210.30.38-0.030.39-0.080.40.38-0.310.33-0.430.41-0.610.24-0.190.230.250.29
0.980.930.980.950.960.980.760.730.930.96-0.610.390.460.950.98-0.930.9-0.980.89-0.710.61-0.610.380.030.69
0.620.70.380.690.640.540.860.360.560.470.17-0.080.460.420.5-0.440.52-0.460.43-0.250.25-0.250.230.050.31
0.940.850.960.870.890.980.690.580.980.84-0.680.40.950.420.95-0.970.87-0.960.95-0.790.43-0.410.360.230.5
0.980.950.950.960.970.980.80.760.940.94-0.610.380.980.50.95-0.920.88-0.970.88-0.740.65-0.530.450.130.69
-0.91-0.81-0.94-0.84-0.86-0.96-0.66-0.6-0.97-0.80.68-0.31-0.93-0.44-0.97-0.92-0.860.93-0.940.76-0.420.48-0.38-0.09-0.5
0.880.840.870.850.870.890.690.630.860.85-0.570.330.90.520.870.88-0.86-0.90.94-0.730.49-0.610.390.140.65
-0.97-0.91-0.97-0.93-0.94-0.97-0.75-0.66-0.93-0.930.6-0.43-0.98-0.46-0.96-0.970.93-0.9-0.90.72-0.520.56-0.27-0.1-0.59
0.880.780.910.810.830.920.630.520.930.77-0.650.410.890.430.950.88-0.940.94-0.9-0.820.36-0.440.410.290.5
-0.69-0.59-0.77-0.61-0.65-0.74-0.46-0.39-0.78-0.590.53-0.61-0.71-0.25-0.79-0.740.76-0.730.72-0.82-0.30.34-0.33-0.32-0.35
0.60.650.530.650.640.550.560.950.430.7-0.330.240.610.250.430.65-0.420.49-0.520.36-0.3-0.510.64-0.210.8
-0.52-0.56-0.6-0.55-0.55-0.47-0.31-0.51-0.4-0.690.26-0.19-0.61-0.25-0.41-0.530.48-0.610.56-0.440.34-0.51-0.120.61-0.7
0.410.380.340.40.370.420.410.610.370.33-0.260.230.380.230.360.45-0.380.39-0.270.41-0.330.64-0.120.20.64
0.110.030.050.050.090.160.17-0.130.19-0.08-0.190.250.030.050.230.13-0.090.14-0.10.29-0.32-0.210.610.2-0.2
0.660.710.630.70.680.60.550.770.470.79-0.320.290.690.310.50.69-0.50.65-0.590.5-0.350.8-0.70.64-0.2
Click cells to compare fundamentals

Stryker EBITDA Historical Pattern

Today, most investors in Stryker Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stryker's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Stryker ebitda as a starting point in their analysis.
   Stryker EBITDA   
       Timeline  
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Stryker Ebitda

Ebitda

5.2 Billion

At this time, Stryker's EBITDA is quite stable compared to the past year.
According to the company disclosure, Stryker reported earnings before interest,tax, depreciation and amortization of 4.95 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 27.02% lower than that of the firm.

Stryker EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stryker's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stryker could also be used in its relative valuation, which is a method of valuing Stryker by comparing valuation metrics of similar companies.
Stryker is currently under evaluation in ebitda category among related companies.

Stryker ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Stryker's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Stryker's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Stryker Institutional Holders

Institutional Holdings refers to the ownership stake in Stryker that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Stryker's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Stryker's value.
Shares
Fundsmith Llp2023-12-31
5.5 M
Morgan Stanley - Brokerage Accounts2023-12-31
5.4 M
Goldman Sachs Group Inc2023-12-31
4.8 M
Franklin Resources Inc2023-12-31
4.7 M
Norges Bank2023-12-31
4.2 M
Fisher Asset Management, Llc2023-12-31
M
First Western Trust Bank2023-12-31
3.8 M
Northern Trust Corp2023-12-31
3.4 M
Legal & General Group Plc2023-12-31
2.9 M
Vanguard Group Inc2023-12-31
31.1 M
Blackrock Inc2023-12-31
24.9 M

Stryker Fundamentals

About Stryker Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Stryker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stryker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stryker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out Stryker Piotroski F Score and Stryker Altman Z Score analysis.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.027
Dividend Share
3.05
Earnings Share
8.24
Revenue Per Share
53.999
Quarterly Revenue Growth
0.118
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.